Abstract:BACKGROUND:ERBB3 binding protein 1 (EBP1) gene transfer into human salivary adenoid cystic carcinoma cells has been shown to significantly inhibit cell proliferation and reduce tumor metastasis in mouse models. In the current study, to evaluate if EBP1 is a novel biomarker capable of identifying patients at higher risk of disease progression and recurrence, we examined the EBP1 expression profile in adenoid cystic carcinoma (ACC) patients and analyzed its clinicopathological relevance. To understand the underlying anti-metastatic mechanism, we investigated if EBP1 regulates invasion-related molecules.METHODS:We performed immunohistochemical analysis on 132 primary adenoid cystic carcinoma and adjacent non-cancerous tissues using commercial EBP1, MMP9, E-cadherin and ICAM-1 antibodies. Results were correlated to clinicopathological parameters, long-term survival and invasion-related molecules by statistical analysis. Cell motility and invasiveness of vector or wild-type EBP1-transfected ACC-M cell lines were evaluated using wound healing and Boyden chamber assays. MMP9, E-cadherin and ICAM-1 proteins in these cell lines were detected using western blot assay.RESULTS:The expression of EBP1 was significantly higher in non-cancerous adjacent tissues compared with corresponding cancer tissues. The intensity and percentage of cells that reacted with EBP1 antibodies were significantly higher in cases with tubular pattern than those with solid pattern (P<0.0001). We also found adenoid cystic carcinoma with local lymphatic metastasis had significantly lower EBP1 expression than ACC with no local lymphatic node metastasis (P<0.0001). Similar findings were observed in ACC with lung metastasis compared with cases with no lung metastasis (P<0.0001), in particular, in cases with perineural invasion compared with cases with no perineural invasion (P<0.0001). Furthermore, a decrease in EBP1 expression was positively associated with a reduction in overall survival of ACC patients. Of note, EBP1 inhibits migration and invasiveness of ACC cells by upregulating E-cadherin but downregulating MMP9. In clinical adenoid cystic carcinoma patients, higher EBP1 expression was positively correlated with E-cadherin levels (P<0.001) but negatively correlated with MMP9 expression (P=0.0002).CONCLUSIONS:EBP1 expression is reduced in adenoid cystic carcinoma, indicating unfavorable prognosis of ACC patients. Its regulation of MMP9 and E-cadherin protein levels suggests a critical therapeutic potential.

Type III TGF-β Receptor Inhibits Cell Proliferation and Migration in Salivary Glands Adenoid Cystic Carcinoma by Suppressing NF-κB Signaling.

Overexpression of Transforming Growth Factor Type III Receptor Restores TGF-β1 Sensitivity in Human Tongue Squamous Cell Carcinoma Cells

Tgf-Beta 1 Promotes Migration and Invasion of Salivary Adenoid Cystic Carcinoma

Epigallocatechin Gallate Inhibits the Growth of Salivary Adenoid Cystic Carcinoma Cells Via the EGFR/Erk Signal Transduction Pathway and the Mitochondria Apoptosis Pathway.

A20 Inhibits Human Salivary Adenoid Cystic Carcinoma Cells Invasion Via Blocking Nuclear Factor-Kappa B Activation

Transforming Growth Factor-Β and Epithelial–mesenchymal Transition Are Associated with Pulmonary Metastasis in Adenoid Cystic Carcinoma

Expression of ERBB3 Binding Protein 1 (EBP1) in Salivary Adenoid Cystic Carcinoma and Its Clinicopathological Relevance.

Suppression Of Salivary Adenoid Cystic Carcinoma Growth And Metastasis By Erbb3 Binding Protein Ebp1 Gene Transfer

Expression and clinical significance of TGF-β1, MAPK in salivary adenoid cystic carcinoma

Nerve Growth Factor and Tyrosine Kinase A in Human Salivary Adenoid Cystic Carcinoma: Expression Patterns and Effects on in Vitro Invasive Behavior

The type III TGF-β receptor regulates epithelial and cancer cell migration through β-arrestin2-mediated activation of Cdc42

Promoting SACC Invasion by TGF-β 1 805 MATERIAlS & METHODS Cell Culture

TACE-Mediated Ectodomain Shedding of the Type I TGF-b Receptor Downregulates TGF-b Signaling

Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication

Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma

Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.

Abstract PR07: Oncogene addition to MYB-NFIB in adenoid cystic carcinomas induced in transgenic mice

Silencing geranylgeranyltransferase I inhibits the migration and invasion of salivary adenoid cystic carcinoma through RhoA/ROCK1/MLC signaling and suppresses proliferation through cell cycle regulation

The MYB/miR-130a/NDRG2 Axis Modulates Tumor Proliferation and Metastatic Potential in Salivary Adenoid Cystic Carcinoma.

TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting the PI3K/AKT pathway and EMT

MicroRNA155 in the Growth and Invasion of Salivary Adenoid Cystic Carcinoma.